Authors
Benjamin Herzberg, MD, is an assistant professor of medicine at Columbia University Medical Center and an oncologist at Herbert Irving Comprehensive Cancer Center in New York, New York
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Durvalumab Plus Enfortumab Vedotin for Cisplatin-Ineligible MIBC
2
Cardiovascular and Bleeding Risk With BTK Inhibitors in CLL
3
Dr Gleave on Selecting Patients for Perioperative Therapy in High-Risk Prostate Cancer
4
Dr Calais on Individualizing PSMA-Targeted Therapy Sequencing in Prostate Cancer
5

